Research ExplorerScientific StaffDaniel J. Smit

Dr. med. Dr. rer. biol. hum. ID: 21009016

Daniel J. Smit

graph of relations
Affiliations
Links
ORCID: 0000-0002-3190-9511
Download CV

Research Interests

Dr. Dr. Daniel J. Smit (MD/PhD) is a research group leader and physician that currently works at the Institute of Tumor Biology, University Medical Center Hamburg-Eppendorf. Daniel does research in Cancer Research, Liquid Biopsy, Molecular Biology, Biochemistry and Signal Transduction.

Publications

Sentinel lymph node risk prognostication in primary cutaneous melanoma through tissue-based profiling, potentially redefining the need for sentinel lymph node biopsy

Research output: SCORING: Contribution to journal › SCORING: Review article › Research

High Serum Levels of CCL20 Are Associated with Recurrence and Unfavorable Overall Survival in Advanced Melanoma Patients Receiving Immunotherapy

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Circulating tumor cells as liquid biopsy markers in cancer patients

Research output: SCORING: Contribution to journal › SCORING: Review article › Research

K-Ras(V12) differentially affects the three Akt isoforms in lung and pancreatic carcinoma cells and upregulates E-cadherin and NCAM via Akt3

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Liquid Biopsy – Ein neues diagnostisches Konzept in der Onkologie

Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research

Impact of AKT1 on cell invasion and radiosensitivity in a triple negative breast cancer cell line developing brain metastasis

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

„Liquid biopsy“ – schon reif für Therapieentscheidungen?

Research output: SCORING: Contribution to journal › SCORING: Review article › Research

Liquid Biopsy  – Ein neues diagnostisches Konzept in der Onkologie

Research output: SCORING: Contribution to journal › SCORING: Review article › Research

The Role of PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma Metabolism

Research output: SCORING: Contribution to journal › SCORING: Review article › Research

TIGIT blockade repolarizes AML-associated TIGIT+ M2 macrophages to an M1 phenotype and increases CD47-mediated phagocytosis

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

View all (26)